Xalkori
Active substance: crizotinib
CAPSULE, COATED PELLETS · CRIZOTINIB 150 mg/1
United StatesActive
Marketing holder: Pfizer Laboratories Div Pfizer Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- CRIZOTINIB · 150 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3967-7cc9-8296-453bada0c7a6,01a1208c-e870-70fe-b3cb-ce5b9bcc3c00,01a1208c-f5b8-79cc-bfed-f43f3fc65d27,01a1208f-7e11-70f9-9756-68fd5acf2da9,01a12093-2cdc-7126-a7ee-3525369f574d;count=5 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0069-1500
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0069-1500 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0069-1500 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0069-1500 · Verified 2026-10-09 · open in source